MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0029961
Daywish Pharma Private Limited
Daywish Pharma Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹30.21 Lakh
▼ 14% YoY
Net loss · FY 2024
₹22,683
Net margin -0.8%
EBITDA · FY 2024
₹59,258
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Daywish Pharma Private Limited
Data last updated:
Daywish Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 04 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2015PTC288150. Its GSTIN is 07AAFCD6852K1ZB (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Tyagi and Bhupendra Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pvt No. 7 – 8 – 9 Basement Property No. 1/6 Industrial Area Kirti Nagar, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.21 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹22,683 (net margin -0.8%) and EBITDA of ₹59,258 (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 10% over five years.
Daywish Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0029961). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Daywish Pharma Private Limited
CIN U24233DL2015PTC288150
Registration Number 288150
Incorporation Date 04 December 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0029961
Key People
Amit Tyagi Director Bhupendra Choudhary Director Recognitions & Rankings of Daywish Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPvt No. 7 – 8 – 9 Basement Property No. 1/6 Industrial Area Kirti Nagar, New Delhi, Delhi, India – 110015
- IndustryTrading, Other Wholesale, Wholesale
Comprehensive company report
Daywish Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Daywish Pharma Private Limited
The main business activity of Daywish Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Daywish Pharma Private Limited FY 2025 filings available
Daywish Pharma Private Limited reported revenue of ₹30.21 Lakh (down 14% YoY) for FY 2024.
Revenue · FY 2024
₹30.21 Lakh ▼ 14%
Net loss · FY 2024
₹22,683 margin -0.8%
EBITDA · FY 2024
₹59,258 margin 2%
Compounded Annual Growth Rate (CAGR) of Daywish Pharma Private Limited
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 16%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 10%
5 years · compounded
▲ 6%
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Daywish Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹59,258 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹22,683 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Daywish Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Daywish Pharma are in the company report.
Premium access
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Daywish Pharma Private Limited
Daywish Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Tyagi | Director | 04 Dec 2015 | 10 Years 10 Months | Current |
| Bhupendra Choudhary | Director | 09 Mar 2016 | 10 Years 7 Months | Current |
Peer Comparison of Daywish Pharma Private Limited
Daywish Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vihaarya Automation Private Limited | ₹30.23 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| Sam Aqurovet Private Limited | ₹30.23 Lakh (FY 2024) | •••• | •••• | 137.0% | •••• | Baruipur, West Bengal, India |
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Naini, Uttar Pradesh, India |
| Ushodaya Suppliers Private Limited | ₹30.22 Lakh (FY 2020) | •••• | •••• | -40.0% | •••• | Kolkata, West Bengal, India |
| Aayurmax Pharma Private Limited | ₹30.22 Lakh (FY 2020) | •••• | •••• | •••• | Pragpura, Rajasthan, India | |
| Daywish Pharma Private Limited this company | ₹30.21 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | New Delhi, Delhi, India |
| Quickzart Private Limited | ₹30.21 Lakh (FY 2024) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Siluck Hybrid Seeds Private Limited | ₹30.21 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Deoli, Rajasthan, India |
| Ghed Fish and Farmers Producer Company Limited | ₹30.21 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Panidhra, Gujarat, India |
| Virtual Dealer Private Limited | ₹30.21 Lakh (FY 2024) | •••• | •••• | -64.0% | •••• | Howrah, West Bengal, India |
| Soilagro Crop Science Private Limited | ₹30.21 Lakh (FY 2024) | •••• | •••• | 169.0% | •••• | Raipur, Chhattisgarh, India |
Peers are the five companies nearest above and the five nearest below Daywish Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Daywish Pharma Private Limited
Daywish Pharma Private Limited is audited by G R & COMPANY for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G R & COMPANY | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Daywish Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Daywish Pharma Private Limited
Daywish Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Daywish Pharma Private Limited
Employment history and EPFO contributions of people linked to Daywish Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Daywish Pharma Private Limited
Daywish Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Bhupendra Choudhary ceased to be Additional Director on 30 Sep 2016.
AGM
Daywish Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Daywish Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Bhupendra Choudhary ceased to be Additional Director.
Ceased
Vijay Pal ceased to be Director.
Appointed
Bhupendra Choudhary was appointed as Director.
Appointed
Amit Tyagi was appointed as Director.
Incorporation
04 Dec 2015
Daywish Pharma Private Limited was registered on 04 Dec 2015 with Roc Delhi & aged 10 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Daywish Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Daywish Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Daywish Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Daywish Pharma Private Limited
Daywish Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD6852K1ZB | Delhi | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Daywish Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daywish Pharma Private Limited
Daywish Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 04 December 2015 (11+ years old) and is registered under CIN U24233DL2015PTC288150.
Daywish Pharma reported revenue of ₹30.21 Lakh for FY 2024 (down 14% YoY).
Daywish Pharma has 2 current directors:
- Amit Tyagi - Director
- Bhupendra Choudhary - Director
Daywish Pharma reported a net loss of ₹22,683 (net margin -0.8%) and EBITDA of ₹59,258 (EBITDA margin 2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Daywish Pharma is 16% over three years and 10% over five years. In the latest year (FY 2024) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Daywish Pharma is 07AAFCD6852K1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Daywish Pharma is U24233DL2015PTC288150. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daywish Pharma was incorporated on 04 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Daywish Pharma by revenue are Vihaarya Automation Private Limited, Sam Aqurovet Private Limited, Maxelon Pharmaceuticals Private Limited, Ushodaya Suppliers Private Limited, Aayurmax Pharma Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Bhupendra Choudhary ceased to be Additional Director on 30 Sep 2016. Vijay Pal ceased to be Director on 10 Mar 2016. Bhupendra Choudhary was appointed as Director on 09 Mar 2016. Daywish Pharma has 4 board changes on record in total.
Yes, Daywish Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0029961).